Heart Disease Trial, Recruiting (NCT07133984)

Heart Disease Trial, Recruiting NCT07133984 Sponsor: Weill Medical College of Cornell University Condition: Heart Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07133984 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Heart Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults aged 18 or older, both men and women
People whose heart pumps at a reduced capacity (specifically, the heart's pumping strength is 40% or less), confirmed by a heart scan done within the past 2 months
People who have significant blockages in multiple important heart arteries, or a serious blockage in the main artery supplying the heart, confirmed by specialised heart artery testing
People who have a heart procedure — either bypass surgery (CABG) or a stent procedure (PCI) — planned within the next 3 months

Who may not be able to join:

People who also have a heart valve problem or another heart condition (such as a bulge in the heart wall) that would need to be repaired or replaced during surgery
People who cannot safely have an MRI scan (for example, due to certain metal implants in the body), or who cannot receive certain contrast dyes or medications used during heart imaging tests (confirm with trial site)
People who currently have an active cancer, or a serious illness affecting major organs, where life expectancy is expected to be less than 5 years

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07133984

Sponsor: Weill Medical College of Cornell University

Phase: Not Applicable

Status: Recruiting

Condition: Heart Disease

More information: https://clinicaltrials.gov/study/NCT07133984

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults aged 18 or older, both men and women
People whose heart pumps at a reduced capacity (specifically, the heart's pumping strength is 40% or less), confirmed by a heart scan done within the past 2 months
People who have significant blockages in multiple important heart arteries, or a serious blockage in the main artery supplying the heart, confirmed by specialised heart artery testing
People who have a heart procedure — either bypass surgery (CABG) or a stent procedure (PCI) — planned within the next 3 months

Who may not be able to join:

People who also have a heart valve problem or another heart condition (such as a bulge in the heart wall) that would need to be repaired or replaced during surgery
People who cannot safely have an MRI scan (for example, due to certain metal implants in the body), or who cannot receive certain contrast dyes or medications used during heart imaging tests (confirm with trial site)
People who currently have an active cancer, or a serious illness affecting major organs, where life expectancy is expected to be less than 5 years

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Weill Medical College of Cornell University

Registry

ClinicalTrials.gov

Start date

1 March 2024

Est. completion

1 August 2028

Where this trial is recruiting

🇦🇹 Austria 🇨🇦 Canada 🇨🇳 China 🇷🇸 Serbia 🇺🇸 United States

Primary endpoints

Cardiac Magnetic Resonance Imaging (CMR) Indices

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov